FDA Inspection 1181895 — Matrix Pharmacorp Private Limited

Matrix Pharmacorp Private Limited — FEI 3003227156

The FDA completed an inspection of Matrix Pharmacorp Private Limited on Sep 17, 2022 in Hyderabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 17, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hyderabad (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.